Related Experiment Videos
Phenylalanine hydroxylase in melanoma cells
Journal of Cellular Physiology
|March 1, 1978
Summary
Melanoma cells can synthesize tyrosine from phenylalanine using phenylalanine hydroxylase. This enzyme activity enables melanoma cell growth in tyrosine-deficient environments, crucial for understanding melanoma metabolism.
Area of Science:
- Biochemistry
- Cell Biology
- Melanoma Research
Background:
- Cloudman S91 melanoma cells (PS1-wild type) exhibit unique metabolic capabilities.
- Understanding nutrient utilization in cancer cells is vital for therapeutic development.
Purpose of the Study:
- To identify the enzymatic basis for melanoma cell growth in tyrosine-free media.
- To characterize the specific hydroxylase activity responsible for phenylalanine conversion.
Main Methods:
- Metabolic analysis of [14C]phenylalanine in living melanoma cells.
- Enzyme assays for phenylalanine hydroxylase in cell extracts.
- Enzyme characterization using specific inhibitors and immunoprecipitation.
Main Results:
- Melanoma cells convert phenylalanine to tyrosine, supporting growth without exogenous tyrosine.
- This conversion is mediated by phenylalanine hydroxylase, not other hydroxylases or tyrosinase.
- Phenylalanine hydroxylase activity was confirmed through inhibition studies and immunological assays.
Conclusions:
- Melanoma cells possess functional phenylalanine hydroxylase, enabling de novo tyrosine synthesis.
- This metabolic adaptation is a key factor in the survival of melanoma cells in specific nutrient conditions.